 "GSK in exclusive talks with Unilever to sell its Horlicks biz for $4 bn")
GlaxoSmithKline Plc is in exclusive talks to sell its Indian Horlicks nutrition business to Unilever Plc, putting an end to an auction that is expected to fetch more than $4 billion, Financial Times reported on Tuesday.
GlaxoSmithKline beat a rival bid from Swiss rival Nestle which was also bidding for the unit and looking to expand its portfolio in the powdered hot beverages category, the report added.
In September, sources had told Reuters that Nestle, Unilever and Coca-Cola were among bidders for GSK's Indian Horlicks nutrition business and that Nestle was particularly well-suited to buy the business.
GSK and Unilever did not immediately respond to a request seeking comment outside regular business hours.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app